• 4D Molecular Therapeutics (NASDAQ:FDMT) Stock Rating Lowered by BMO Capital Markets

    المصدر: Buzz FX / 13 يناير 2025 08:21:16   America/New_York


    4D Molecular Therapeutics (NASDAQ:FDMT) Stock Rating Lowered by BMO Capital Markets Written by MarketBeat January 13, 2025 Share Link copied to clipboard. 4D Molecular Therapeutics ( NASDAQ:FDMT - Get Free Report ) was downgraded by investm
    Read more...
شارك على،